agilon health, inc.

1. 01

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +15.4% (SPY −1.6%, XLV +13.5%). 3 months: −10.8% (SPY −0.4%, XLV +15.5%). 1 year: +431.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: AGL, SPY and XLV · as of 4 Nov 2026

2. 02

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $96.23 was 9.9% above its 50-day average ($87.55) and 45.9% above its 200-day average ($65.97). It has closed above the 200-day for 142 sessions, since 15 Apr 2026. The 50-day average crossed above the 200-day on 13 May 2026, 121 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

3. 03

   71% of the way up its 52-week range

   Closed at $96.23 on 4 Nov 2026: 27.7% below the 52-week high of $133.04 (17 Jul 2026) and 1186.5% above the low of $7.48 (31 Mar 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

4. 04

   Short interest at 5.4% of shares outstanding

   899.1K shares were sold short at the 15 Oct 2026 settlement, 5.4% of the 16.8M shares outstanding; covering them would take 4.6 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close